Oncology Today with Dr Neil Love: Key Presentations on Multiple Myeloma from Recent Major Oncology/Hematology Conferences
Hematologic Oncology Update
00:00
Intermittent Therapy and MRD Positivity in Prostate Cancer
The chapter discusses the use of PSA as a marker in prostate cancer and the potential for intermittent therapy based on MRD positivity.
Transcript
Play full episode
